Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergic contact dermatitis from mercapto compounds.

Alison K Adams1, Erin M Warshaw

  • 1Department of Dermatology, University of Minnesota Veterans Affairs Medical Center, Minneapolis, MN 55417, USA.

Dermatitis : Contact, Atopic, Occupational, Drug
|September 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Occupational contact dermatitis in North American health care workers: Trends and triggers (2005-2022).

Journal of the American Academy of Dermatology·2026
Same author

Patch Test Reactions Associated with Food Sources: A Retrospective Analysis of the North American Contact Dermatitis Group Data (2001-2018).

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Anatomical Locations of Keratinocyte Carcinomas Among United States Veterans Affairs Healthcare System Patients in Minnesota: A Cross-Sectional Study.

Experimental dermatology·2025
Same author

Comparison Between Brazilian Propolis and Chinese Propolis: Results From the North American Contact Dermatitis Group 2019-2022.

Dermatitis : contact, atopic, occupational, drug·2025
Same author

North American Contact Dermatitis Group Patch Test Results: 2021-2022.

Dermatitis : contact, atopic, occupational, drug·2025
Same journal

The Toxin of the Year: Airborne PM<sub>2.5</sub>.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Eyelid Dermatitis: A 5-Year Retrospective Review from a Metropolitan Contact Dermatitis Clinic.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

<i>Letter:</i> Anogenital Dermatitis Rarely Occurs in Isolation: Disease Distribution and Delays in Patch Testing.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Practical Techniques: Photopatch Testing.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Digital Image Superimposition for Identifying Delayed Patch Test Reactions: A Clinical Pearl.

Dermatitis : contact, atopic, occupational, drug·2026
See all related articles

Mercaptobenzothiazole and its derivatives are common allergens found in rubber and other products. This review covers the epidemiology and clinical features of allergic contact dermatitis caused by these mercapto compounds.

Area of Science:

  • Dermatology
  • Allergology
  • Occupational Health

Background:

  • Mercaptobenzothiazole and its derivatives are widely utilized in various industries, including rubber manufacturing and mining.
  • These compounds are recognized as significant allergens, posing risks for allergic contact dermatitis.
  • Despite known allergenic potential, their use remains prevalent in diverse consumer and industrial products.

Purpose of the Study:

  • To review the current epidemiology of allergic contact dermatitis linked to mercapto compounds.
  • To describe the clinical characteristics associated with allergic reactions to mercaptobenzothiazole and its derivatives.

Main Methods:

  • Literature review of epidemiological studies.
  • Analysis of clinical case reports and series.

Related Experiment Videos

  • Synthesis of data on exposure sources and clinical presentations.
  • Main Results:

    • Data on the prevalence and incidence of allergic contact dermatitis from mercapto compounds were compiled.
    • Common clinical manifestations, diagnostic approaches, and management strategies were identified.
    • Key exposure pathways in occupational and non-occupational settings were highlighted.

    Conclusions:

    • Allergic contact dermatitis from mercaptobenzothiazole and derivatives remains a relevant clinical issue.
    • Understanding the epidemiology and clinical presentation is crucial for diagnosis and prevention.
    • Continued vigilance and awareness are necessary due to the widespread use of these chemicals.